Plus Therapeutics: Funding, Investors & Team (Oct 2026)
Plus Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. It is a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery, and other serious, chronic, and life-threatening conditions. Plus Therapeutics pipeline of candidate drug products includes their lead drug product candidates, RNL and DocePLUS, which are being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, physicians, and other professionals.
Plus Therapeutics has raised $17.6M across 1 funding round on record, the most recent a Grant of $17.6M announced in Aug 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Plus Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Plus Therapeutics Funding Rounds
Plus Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Plus Therapeutics Funding Compared to Other Biotechnology Startups
Plus Therapeutics' latest round of $17.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Plus Therapeutics in Biotechnology and Austin
Companies Similar to Plus Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Plus Therapeutics Funding FAQs
What does Plus Therapeutics do?
Plus Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. It is a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery, and other serious, chronic, and life-threatening conditions. Plus Therapeutics pipeline of candidate drug products includes their lead drug product candidates, RNL and DocePLUS, which are being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, physicians, and other professionals.
How much funding has Plus Therapeutics raised?
Plus Therapeutics has raised $17.6M across 1 round on record. The most recent is a Grant of $17.6M announced in Aug 2022.
When did Plus Therapeutics last raise funding?
Plus Therapeutics' most recent funding round on record is a Grant of $17.6M, announced in Aug 2022.
Who is the CEO of Plus Therapeutics?
Marc Hedrick is listed as CEO at Plus Therapeutics.
Where is Plus Therapeutics headquartered?
Plus Therapeutics is based in Austin, Texas, United States.
How many employees does Plus Therapeutics have?
Plus Therapeutics is in the 11-50 employee band.
How does Plus Therapeutics' funding compare to other Biotechnology startups?
Plus Therapeutics' latest round of $17.6M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Plus Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Plus Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.